BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Paik WH, Ryu JK, Jeong KS, Park JM, Song BJ, Lee SH, Kim YT, Yoon YB. Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer. World J Gastroenterol 2014; 20(26): 8545-8557 [PMID: 25024609 DOI: 10.3748/wjg.v20.i26.8545]
URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8545.htm
Number Citing Articles
1
Xiaojia Ji, Kevin P Williams, Weifan Zheng. Applying a Gene Reversal Rate Computational Methodology to Identify Drugs for a Rare Cancer: Inflammatory Breast CancerCancer Informatics 2023; 22 doi: 10.1177/11769351231202588
2
Yan-yan Zhao, Jing Jia, Jing-jing Zhang, Yan-ping Xun, Shu-jun Xie, Jia-feng Liang, Hong-gang Guo, Jia-zhen Zhu, Sheng-lin Ma, Shi-rong Zhang. Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMTActa Pharmacologica Sinica 2021; 42(8): 1288 doi: 10.1038/s41401-020-00548-6
3
Noelia A Massari, Melisa B Nicoud, Vanina A Medina. Histamine receptors and cancer pharmacology: an updateBritish Journal of Pharmacology 2020; 177(3): 516 doi: 10.1111/bph.14535
4
Tamara E. Galarza, Mónica A. Táquez Delgado, Nora A. Mohamad, Gabriela A. Martín, Graciela P. Cricco. Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cellsBiochemical Pharmacology 2020; 180: 114177 doi: 10.1016/j.bcp.2020.114177
5
Adriana María Belén Abiuso, María Luisa Varela, Luis Haro Durand, Marcos Besio Moreno, Alejandra Marcos, Roberto Ponzio, Marco Aurelio Rivarola, Alicia Belgorosky, Omar Pedro Pignataro, Esperanza Berensztein, Carolina Mondillo. Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boysEuropean Journal of Cancer 2018; 91: 125 doi: 10.1016/j.ejca.2017.12.003
6
Dominik Awad, Michael Prattes, Lisa Kofler, Ingrid Rössler, Mathias Loibl, Melanie Pertl, Gertrude Zisser, Heimo Wolinski, Brigitte Pertschy, Helmut Bergler. Inhibiting eukaryotic ribosome biogenesisBMC Biology 2019; 17(1) doi: 10.1186/s12915-019-0664-2
7
Alana Aragón-Herrera, Marinela Couselo-Seijas, Sandra Feijóo-Bandín, Laura Anido-Varela, Sandra Moraña-Fernández, Estefanía Tarazón, Esther Roselló-Lletí, Manuel Portolés, José Luis Martínez-Sande, Javier García-Seara, Ezequiel Álvarez, José Ramón González-Juanatey, Moisés Rodríguez-Mañero, Sonia Eiras, Francisca Lago. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markersScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-26836-1
8
Mitra Abbasifard, Kowsar Bagherzadeh, Hossein Khorramdelazad. The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1410104
9
Takuji Tanaka, Takahiro Kochi, Yohei Shirakami, Takayuki Mori, Ayumi Kurata, Naoki Watanabe, Hisataka Moriwaki, Masahito Shimizu. Cimetidine and Clobenpropit Attenuate Inflammation-Associated Colorectal Carcinogenesis in Male ICR MiceCancers 2016; 8(2): 25 doi: 10.3390/cancers8020025
10
Enrique Domínguez‐Álvarez, Dorota Łażewska, Zsanett Szabó, Stefanie Hagenow, David Reiner, Márió Gajdács, Gabriella Spengler, Holger Stark, Jadwiga Handzlik, Katarzyna Kieć‐Kononowicz. The Search for Histamine H4 Receptor Ligands with Anticancer Activity among Novel (Thio)urea DerivativesChemistrySelect 2019; 4(36): 10943 doi: 10.1002/slct.201902747
11
Melisa B. Nicoud, Karina Formoso, Vanina A. Medina. Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic ImplicationsFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00556
12
Phuong Linh Nguyen, Jungsook Cho. Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular TargetsBiomolecules 2021; 11(8): 1232 doi: 10.3390/biom11081232
13
Tamara E. Galarza, Nora A. Mohamad, Mónica A. Táquez Delgado, Guadalupe M. Vedoya, Ernesto J. Crescenti, Rosa M. Bergoc, Gabriela A. Martín, Graciela P. Cricco. Histamine prevents radiation-induced mesenchymal changes in breast cancer cellsPharmacological Research 2016; 111: 731 doi: 10.1016/j.phrs.2016.07.039
14
Poonam Yadav, Raghupathy Vengoji, Maneesh Jain, Surinder K. Batra, Nicole Shonka. Pathophysiological role of histamine signaling and its implications in glioblastomaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(5): 189146 doi: 10.1016/j.bbcan.2024.189146